Match!
Ping Zhang
Centers for Disease Control and Prevention
EndocrinologyPhysical therapyType 2 diabetesDiabetes mellitusMedicine
135Publications
38H-index
7,152Citations
What is this?
Publications 138
Newest
#2Xiaohui Zhuo (CDC: Centers for Disease Control and Prevention)H-Index: 3
Last. Matthias B. Schulze (University of Potsdam)H-Index: 71
view all 9 authors...
Aims Although risk scores to predict type 2 diabetes exist, cost-effectiveness of risk thresholds to target prevention interventions are unknown. We applied cost-effectiveness analysis to identify optimal thresholds of predicted risk to target a low-cost community-based intervention in the USA.
1 CitationsSource
#1Rhys Williams (Swansea University)H-Index: 23
#2Suvi Karuranga (International Diabetes Federation)H-Index: 2
Last. Ping Zhang (CDC: Centers for Disease Control and Prevention)H-Index: 38
view all 11 authors...
Abstract Aims Diabetes and its complications have a significant economic impact on individuals and their families, health systems and national economies. Methods The direct health expenditure of diabetes was calculated relying on the following inputs: diagnosed and undiagnosed diabetes prevalence estimates, United Nations population estimates, World Health Organization health expenditure per capita and ratios of health expenditure for people with diabetes compared to people without diabetes. Res...
2 CitationsSource
#1Hui Shao (UF: University of Florida)
#2Ji Lin (CDC: Centers for Disease Control and Prevention)H-Index: 6
Last. Ping Zhang (CDC: Centers for Disease Control and Prevention)H-Index: 38
view all 6 authors...
OBJECTIVE Guidelines on the standard care of diabetes recommend that glycemic treatment goals for older adults consider the patient’s complications and life expectancy. In this study, we examined the influence of diabetes complications and associated life expectancies on the cost-effectiveness (CE) of HbA1c treatment goals. RESEARCH DESIGN AND METHODS We used data from the 2011–2016 National Health and Nutrition Examination Survey (NHANES) to generate nationally representative subgroups of older...
Source
#1Sharon Saydah (CDC: Centers for Disease Control and Prevention)H-Index: 37
#2Sundar S. Shrestha (CDC: Centers for Disease Control and Prevention)H-Index: 11
Last. Giuseppina Imperatore (CDC: Centers for Disease Control and Prevention)H-Index: 54
view all 5 authors...
OBJECTIVE While diabetic ketoacidosis (DKA) is common in youth at the onset of the diabetes, the excess costs associated with DKA are unknown. We aimed to quantify the health care services use and medical care costs related to the presence of DKA at diagnosis of diabetes. RESEARCH DESIGN AND METHODS We analyzed data from the U.S. MarketScan claims database for 4,988 enrollees aged 3–19 years insured in private fee-for-service plans and newly diagnosed with diabetes during 2010–2016. Youth with a...
1 CitationsSource
#1Guangwei Li (Academy of Medical Sciences, United Kingdom)H-Index: 11
#2Ping Zhang (CDC: Centers for Disease Control and Prevention)H-Index: 38
Last. Peter H. Bennett (NIH: National Institutes of Health)H-Index: 89
view all 3 authors...
Source
#1Seamus Kent (University of Oxford)H-Index: 8
#2Frauke Becker (University of Oxford)H-Index: 5
Last. Philip Clarke (University of Oxford)H-Index: 35
view all 18 authors...
Transparency in health economic decision modelling is important for engendering confidence in the models and in the reliability of model-based cost-effectiveness analyses. The Mount Hood Diabetes Challenge Network has taken a lead in promoting transparency through validation with biennial conferences in which diabetes modelling groups meet to compare simulated outcomes of pre-specified scenarios often based on the results of pivotal clinical trials. Model registration is a potential method for p...
1 CitationsSource
#2Michael LaxyH-Index: 1
Last. Ping ZhangH-Index: 38
view all 6 authors...
Increases in the number of new oral antidiabetic medications in the last decade have resulted in a change in payments. We examined the trends in total payment and patients’ out-of-pocket (OOP) payments on a yearly supply of various oral antidiabetic drug types from 2003 to 2016. We analyzed 1,803,427 adults with diabetes under fee for service plans from the 2003-2016 MarketScan commercial claims database. Antidiabetic drugs were grouped using National Drug Codes. Total and OOP payment for each d...
Source
#1Yanyan ChenH-Index: 2
#2Ping ZhangH-Index: 38
Last. Guangwei LiH-Index: 11
view all 8 authors...
Responses to lifestyle interventions in people with impaired glucose tolerance (IGT) may differ during the intervention phase: some progress to diabetes, some regress to normal glucose tolerance (NGT) and some retain IGT. Whether these different responses to intervention influence subsequent outcomes is uncertain. In 1986, 576 persons with IGT in Da Qing, China, were randomized to control or intervention (diet, exercise, diet plus exercise) groups for a six-year lifestyle intervention. In 1992, ...
Source
#2Michael LaxyH-Index: 1
Last. Ping ZhangH-Index: 38
view all 6 authors...
High spending, especially out-of-pocket (OOP) payment on insulin, could lead individuals with diabetes to skip or ration doses and worsen future health outcomes. We examined the trends in total and OPP payment on a yearly supply of insulin by type from 2003 to 2016. Using the 2003-2016 MarketScan claims database, we analyzed 1,703,343 adults with diabetes who were continuously enrolled in fee-for-service health plans. Insulin was grouped into 6 types (human insulin, Glargine, Lispro, Aspart, Det...
Source
#1Yali AnH-Index: 3
#2Ping ZhangH-Index: 38
Last. Guangwei LiH-Index: 11
view all 9 authors...
Source
12345678910